Cargando…

Evaluation of Pharmacokinetics and Dose Proportionality of Diazepam After Intranasal Administration of NRL‐1 to Healthy Volunteers

NRL‐1 is a novel intranasal formulation of diazepam that is being evaluated as rescue medication in patients with epilepsy who experience bouts of increased seizure activity despite stable regimens of antiepileptic drugs. This phase 1, open‐label, randomized, crossover study in healthy adult volunte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanimoto, Sarina, Pesco Koplowitz, Luana, Lowenthal, Richard E., Koplowitz, Barry, Rabinowicz, Adrian L., Carrazana, Enrique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497078/ https://www.ncbi.nlm.nih.gov/pubmed/31916704 http://dx.doi.org/10.1002/cpdd.767

Ejemplares similares

Bioavailability and safety of diazepam intranasal solution compared to oral and rectal diazepam in healthy volunteers
por: Hogan, R. Edward, et al.
Publicado: (2020)

Pharmacokinetics of the Melanocortin Type 1 Receptor Agonist PL8177 After Subcutaneous Administration
por: Dodd, John, et al.
Publicado: (2021)

Overcoming the challenges of developing an intranasal diazepam rescue therapy for the treatment of seizure clusters
por: Cloyd, James, et al.
Publicado: (2021)

Biorelevant In Vitro Skin Permeation Testing and In Vivo Pharmacokinetic Characterization of Lidocaine from a Nonaqueous Drug-in-Matrix Topical System
por: Greuber, Emileigh, et al.
Publicado: (2021)

Pharmacokinetics and safety of VALTOCO (NRL‐1; diazepam nasal spray) in patients with epilepsy during seizure (ictal/peri‐ictal) and nonseizure (interictal) conditions: A phase 1, open‐label study
por: Hogan, Robert Edward, et al.
Publicado: (2020)

Lack of clinically relevant differences in safety and pharmacokinetics after second‐dose administration of intranasal diazepam within 4 h for acute treatment of seizure clusters: A population analysis
por: Cascino, Gregory D., et al.
Publicado: (2022)

The nose has it: Opportunities and challenges for intranasal drug administration for neurologic conditions including seizure clusters
por: Chung, Steve, et al.
Publicado: (2022)

Optimizing Absorption for Intranasal Delivery of Drugs Targeting the Central Nervous System Using Alkylsaccharide Permeation Enhancers
por: Madden, Stuart, et al.
Publicado: (2023)

Improvement of Intranasal Drug Delivery with Intravail(®) Alkylsaccharide Excipient as a Mucosal Absorption Enhancer Aiding in the Treatment of Conditions of the Central Nervous System
por: Rabinowicz, Adrian L., et al.
Publicado: (2021)

Assessing cardiac safety in oncology drug development
por: Seltzer, Jonathan H, et al.
Publicado: (2019)

Safety of Diazepam Nasal Spray in Pediatric Patients With Developmental Epileptic Encephalopathies: Results From a Long-term Phase 3 Safety Study
por: Tarquinio, Daniel, et al.
Publicado: (2023)

The impact of anaphylaxis on the absorption of intranasal epinephrine in anaesthetized non-naive beagle dogs
por: Sparapani, Samantha, et al.
Publicado: (2023)

Use of intranasal rescue therapy for seizure clusters in students with epilepsy: Nurses’ knowledge, perceptions, and practice
por: Santilli, Nancy, et al.
Publicado: (2023)

Pharmacokinetics of intranasal amiloride in healthy volunteers
por: Yellepeddi, Venkata K., et al.
Publicado: (2023)

Significant improvements in SEIzure interVAL (time between seizure clusters) across time in patients treated with diazepam nasal spray as intermittent rescue therapy for seizure clusters
por: Misra, Sunita N., et al.
Publicado: (2022)

A Physiologically Based Pharmacokinetic Model for Predicting Diazepam Pharmacokinetics after Intravenous, Oral, Intranasal, and Rectal Applications
por: Khalid, Sundus, et al.
Publicado: (2021)

Clay Nanotubes Loaded with Diazepam or Xylazine Permeate the Brain through Intranasal Administration in Mice
por: Yanamadala, Yaswanthi, et al.
Publicado: (2023)

Cognitive mechanisms of diazepam administration: a healthy volunteer model of emotional processing
por: Pringle, A, et al.
Publicado: (2016)

NRL plasma formulary
por: Book, David L
Publicado: (1983)

Brain Targeted Transcranial Administration of Diazepam and Shortening of Sleep Latency in Healthy Human Volunteers
por: Pathirana, W., et al.
Publicado: (2011)

Use of second doses of Valtoco® (diazepam nasal spray) across 24 hours after the initial dose for out‐of‐hospital seizure clusters: Results from a phase 3, open‐label, repeat‐dose safety study
por: Sperling, Michael R., et al.
Publicado: (2022)

Clarification of Dalfampridine Labeled Indications
por: Rabinowicz, Adrian L., et al.
Publicado: (2012)

Pharmacokinetics of Mephedrone Enantiomers in Whole Blood after a Controlled Intranasal Administration to Healthy Human Volunteers
por: Czerwinska, Joanna, et al.
Publicado: (2020)

The pharmacokinetics of intranasal droperidol in volunteers characterised via population modelling
por: Cooper, Isabelle, et al.
Publicado: (2018)

Direct effects of diazepam on emotional processing in healthy volunteers
por: Murphy, S. E., et al.
Publicado: (2008)

Rapid increases in epinephrine concentration following presumed intra–blood vessel administration via epinephrine autoinjector
por: Ebisawa, Motohiro, et al.
Publicado: (2023)

Identification of Nrl1 Domains Responsible for Interactions with RNA-Processing Factors and Regulation of Nrl1 Function by Phosphorylation
por: Mikolaskova, Barbora, et al.
Publicado: (2021)

Antenatal and perinatal factors influencing neonatal blood pressure: a systematic review
por: Rabe, Heike, et al.
Publicado: (2021)

Pharmacokinetics of Nanosomal Form of Levodopa in Intranasal Administration
por: Nedorubov, Andrey Anatolievich, et al.
Publicado: (2019)

A Short Review on the Intranasal Delivery of Diazepam for Treating Acute Repetitive Seizures
por: Boddu, Sai H. S., et al.
Publicado: (2020)

Final results from a Phase 3, long‐term, open‐label, repeat‐dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy
por: Wheless, James W., et al.
Publicado: (2021)

Pharmacokinetics and tolerability of intranasal or intravenous administration of nalbuphine in infants
por: Pfiffner, Miriam, et al.
Publicado: (2023)

Inhibitory Effect of Imperatorin on the Pharmacokinetics of Diazepam In Vitro and In Vivo
por: Zhou, Yunfang, et al.
Publicado: (2020)

Pharmacokinetics of Diazepam and Its Metabolites in Urine of Chinese Participants
por: Wang, Le-le, et al.
Publicado: (2022)

Implications of Seizure-Cluster Treatment on Healthcare Utilization: Use of Approved Rescue Medications
por: Rabinowicz, Adrian L, et al.
Publicado: (2022)

Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long‐term, open‐label safety study
por: Segal, Eric B., et al.
Publicado: (2021)

Lack of Effect of Vortioxetine on the Pharmacokinetics and Pharmacodynamics of Ethanol, Diazepam, and Lithium
por: Chen, Grace, et al.
Publicado: (2016)

Comparison of Intranasal and Intravenous Diazepam on Status Epilepticus in Stroke Patients: A Retrospective Cohort Study
por: Inokuchi, Ryota, et al.
Publicado: (2015)

Consistent safety and tolerability of Valtoco(®) (diazepam nasal spray) in relationship to usage frequency in patients with seizure clusters: Interim results from a phase 3, long‐term, open‐label, repeat‐dose safety study
por: Miller, Ian, et al.
Publicado: (2021)

USL255 extended-release topiramate: Dose-proportional pharmacokinetics and tolerability in healthy volunteers
por: Clark, Annie M, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tnhevn36mg7887ru0oq0afv8o9